SpotSense is a rapid diagnostics company which specializes in high accuracy bedside diagnostic solutions. Their flagship product Droolie is globally the first non-invasive diagnostic tool for newborn sepsis screening. Droolie utilizes a small salivary sample from a baby to look for host-response biomarkers that indicate systemic inflammatory response. The product is augmented with the proprietary sepsis scoring system SepScore which can utilize clinical symptoms, lab data and biomarker levels to accurately predict the risk for mortality and morbidity.
SpotSense also has a range of other tests for clinical applications varying from infectious diseases, respiratory or metabolic disorders, anemia, coagulopathies and other non-communicable diseases. The product VIEWDx, by SpotSense enables easy integration of multiple test formats in a single device.